The excellence in One Health
Nano1Health SL is a company based on rapidly and accurately identifying microorganisms and pathogens from a One Health perspective.
Our B2B company boasts a diverse team combining the unparalleled expertise of veterinarians, geneticists, and bioinformaticians, who are leaders in their respective fields and widely recognized for their significant contributions and achievements.
What?
We develop innovative strategies for rapidly identifying microorganisms, pathogens, and drug-resistance biomarkers. We offer solutions based on nanopore genomic sequencing and expert bioinformatics analysis.
MICROBIOMEMicrobiome analysis of human, animal, and environmental samples, including:
-
Sequencing of the complete 16S rRNA gene for bacteria
We provide accurate resolution to genus/species level, allowing detailed identification of the bacteria present.
-
18S-ITS-28S gene sequencing for fungi and yeasts
We explore genetic diversity in these organisms, providing valuable information on their composition and function.
-
Metagenomics
We use metagenomic approaches to obtain a comprehensive view of the genetic diversity in samples, allowing the identification of specific genes and functions.
PATHOGEN IDENTIFICATION Rapid identification of pathogens and drug resistance biomarkers by agnostic metagenomic sequencing, a unique method to efficiently detect viruses, bacteria, fungi, and parasites.
COMPLETE GENOME SEQUENCING (microorganisms) In-depth characterization of pathogens and drug resistance genes by nanopore whole genome sequencing from microbiological cultures.
NANOPORE SEQUENCING Long read sequencing using nanopore on the Oxford Nanopore Technologies GridION kit, followed by bioinformatics analysis and long-term data storage.
As a CRO, we advice our clients in their projects, addressing the data generation process, such as sequencing, and designing or adapting specific bioinformatics algorithms and pipelines according to their needs.
How?
Our multidisciplinary team stands out for its long history and experience in genomics, bioinformatics, and veterinary clinics. We offer a close and personalized contact for each client.
Knowledge
The team's previous experience and complementarity.
Innovation
State-of-the-art tools, ready to offer innovative, accurate, and affordable solutions.
Unique
With a One Health vision
Who?
We are a multidisciplinary team that combines the experience of veterinarians, geneticists, and bioinformaticians of recognized prestige.
OLGA FRANCINO
PhD Biology
Founding partner of Nano1Health and Vetgenomics. Team leader with extensive experience in implementing and valorizing new genomic methodologies. She is also responsible for Project Management and Innovation of the Veterinary Service of Molecular Genetics (SVGM, UAB).
LLUIS FERRER
DVM, PhD, Dipl ECVD
Founding partner of Nano1Health. Over the past 30 years, his research has focused on understanding the molecular mechanisms of some canine skin diseases, with the ultimate goal of using the dog as a primary non-rodent model for human diseases.
MARC NOGUERA
PhD Chemistry
Founding partner of Nano1Health. Marc works between computing and science. With skills in molecular modeling, genomics, high-performance computing, drug discovery, and DNA sequencing analysis. His specialties are Chemoinformatics, Bioinformatics, Genomics, High Throughput Sequencing, High Performance Computing, Cloud Computing, and Data Analytics.
XAVIER ROURA
DVM, PhD, Dipl ECVIM-CA
Founding partner of Nano1Health. Xavi is a veterinarian specializing in small animal internal medicine at the Veterinary Teaching Hospital de la Universitat Autònoma de Barcelona (Spain), current president of the International Renal Interest Society, and active Canine Leishmaniasis Study Group member.
MONTSE SALA
PhD Molecular Biology
Founding partner of Nano1Health. Focused on implementing and maintaining the Quality Management System, promoting Continuous Improvement. I supervise the activities performed by the team in terms of quality and their responsibilities to verify compliance with legal, customer, and internal requirements.
JOAN MARTÍ-CARRERAS
PhD Biomedical Sciences
Joan holds a Ph.D. in Biomedical Sciences from KU Leuven (Belgium) and is one of the talented additions to the Neotec grant. Her specialties are virology (mainly human pathogens), bioinformatics, and epidemic/pandemic control. He has extensive experience in Illumina and Oxford Nanopore sequencing to obtain viral genomes and analyze their variation in a functional, phylogenetic, and epidemiological context.
MARINA CARRASCO
Bachelor degree Biotechnology
Industrial PhD student in Nano1Health. Graduated in Biotechnology in 2021 from the University of Barcelona. She interned in the Virus Contaminants laboratory in Water and Food. She completed the Official Master in Zoonosis and One Health in 2022 at the Universitat Autònoma de Barcelona.
DANIEL PÉREZ
Bachelor degree Biochemistry
Daniel has a degree in Biochemistry and is a specialist in clinical analysis. He has experience in DNA sequencing with Oxford Nanopore Technologies, microbiome analysis, and whole genome sequencing of bacterial genomes. In addition, he has been involved in the planning and management of several veterinary research projects, establishing and validating genomic analysis methods.
Our clients
We work in different sectors with extensive research backgrounds.
- Pharmaceutical, veterinary, biomedical, biomedical, and agri-food research professionals.
- Research groups or companies with R+D+i projects
- Professionals in the agri-food sector
- Public and private research professionals
